The Road Less Traveled: Honoring 2018 Dr. Paul Janssen Award Winner James Allison
When the cancer-fighting convention focused on tumors, James Allison, Ph.D, chose a different path: focus on the immune system. Although it took several years to convince the oncology community that cancer could be treated without focusing on the tumor itself, his insight eventually led to the rapid evolution of immuno-therapy that today is yielding life-altering treatments and new hope for patients with cancer.
As a leading healthcare company and proud champions of science, we believe that science, technology, engineering and math (STEM) are critical to advancing and enhancing the health of everyone, everywhere. To advance health for humanity through science and technology, Johnson & Johnson Innovation works with many partners to fuel a strong pipeline of the next generation of innovators.
Data to Insights: Addressing Challenges of the Microbiome
A mysterious, complex and largely unknown universe exists within and on you. Every day, as you go about your routine, colossal quantities of microbes that form your unique microbiome are aiding or obstructing your functions. What role can this universe, the human microbiome, play in preventing disease and treating illness? This question has spurred unique in-human research and development strategies, which deliver an abundance of data. Now, what do we do with these data? How do we make meaningful insights and unlock solutions to our health? How do we turn code into tailored interventions and treatments ready for the market?
Meet Eva Wolfangel: European Science Writer of the Year 2018
Congratulations to Eva Woflangel, a freelance science journalist from Germany who received the 2018 European Science Writer of the Year Award at the European Conference of Science Journalists on July 8. Johnson & Johnson Innovation sponsors of the Award, which is organized by the British Science Writers Association.